Latest Developments in Global Surgical Site Infection Control Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Surgical Site Infection Control Market

  • Healthcare
  • Sep 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

 

  • In April 2024, Medtronic reportedly launched an AI-powered wound monitoring platform designed to enable real-time infection risk assessment, marking a significant step in predictive surgical site infection control technologies
  • In April 2024, Destiny Pharma disclosed audited results for 2023, announcing a strategic review to advance its XF-73 nasal gel through Phase III trials. XF-73 is a novel compound aimed at preventing Staphylococcal infections following surgical procedures, with potential to reduce hospitalization stay and accelerate recovery 
  • In December 2023, Flinders University (Australia) and Chinese researchers collaborated to develop a new Ag-Ga orthopedic implant covering highly resistant to infection. This novel material, which can be spray-casted on medical devices, not only protects against infection but also provides an anti-inflammatory effect 
  • In October 2023, Sylke Inc. introduced SYLKE, a dressing manufactured from pure hypoallergenic silk fibroin. SYLKE promotes healing in surgical wounds and aims to reduce complications and infections that might lead to poor scarring, specifically by addressing medical adhesive-related skin damage  
  • In August 2023, research conducted by Emory University, involving over 20,000 patients and utilizing automated methods to provide feedback and evaluate performance, found a 12% increase in antibiotic prophylactic compliance and a 33% decrease in overall SSIs. This highlights the effectiveness of automated antibiotic prophylaxis approaches 
  • In October 2023, Getinge AB (Sweden) acquired Healthmark Industries Co. Inc., an US-based provider of innovative instrument care and infection control consumables. This strategic move strengthens Getinge's footprint in sterile reprocessing, particularly in the U.S. market
  • In May 2025, discussions within the industry highlighted Far-UVC technology as poised to transform indoor infection control, indicating ongoing research and potential deployment in healthcare settings to reduce pathogen transmission in the operating room environment